clofibric acid has been researched along with Acute Kidney Injury in 9 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The average time until acute renal failure diagnosis was 6." | 1.35 | [Fibrate-induced deterioration of renal function]. ( Bello, I; García, F; González, E; Gutiérrez Martínez, E; Gutiérrez-Millet, V; Hernández, E; Morales, E; Polanco, N; Praga, M, 2009) |
| "We report unexpected acute renal failure occurring in 4 patients after uncomplicated cardiac surgery." | 1.31 | Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group. ( Madden, BP; Millner, R; Parker, J; Rolfe, LM; Seymour, CA; Sharobeem, KM, 2000) |
| " The recommended dosage of clofibrate is 1." | 1.26 | [Fat and renal failure--therapeutic aspects]. ( Heidland, A; Hörl, M; Hörl, WH, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yildiz, A | 1 |
| Gucuk, E | 1 |
| Cay, S | 1 |
| Polanco, N | 1 |
| Hernández, E | 1 |
| González, E | 1 |
| Gutiérrez Martínez, E | 1 |
| Bello, I | 1 |
| Gutiérrez-Millet, V | 1 |
| García, F | 1 |
| Morales, E | 1 |
| Praga, M | 1 |
| Li, S | 2 |
| Gokden, N | 1 |
| Okusa, MD | 1 |
| Bhatt, R | 1 |
| Portilla, D | 2 |
| Nagothu, KK | 1 |
| Megyesi, J | 1 |
| Kaissling, B | 1 |
| Schnackenberg, L | 1 |
| Safirstein, RL | 1 |
| Beger, RD | 1 |
| Meffin, PJ | 1 |
| Zilm, DM | 1 |
| Veenendaal, JR | 1 |
| Hörl, WH | 1 |
| Hörl, M | 1 |
| Heidland, A | 1 |
| Heidemann, H | 1 |
| Bock, KD | 1 |
| Ramachandran, S | 1 |
| Giles, PD | 1 |
| Hartland, A | 1 |
| Sharobeem, KM | 1 |
| Madden, BP | 1 |
| Millner, R | 1 |
| Rolfe, LM | 1 |
| Seymour, CA | 1 |
| Parker, J | 1 |
9 other studies available for clofibric acid and Acute Kidney Injury
| Article | Year |
|---|---|
A case of rhabdomyolysis and thromboembolic event secondary to fibrate monotherapy.
Topics: Acute Kidney Injury; Aged; Clofibric Acid; Humans; Hypolipidemic Agents; Male; Rhabdomyolysis; Risk | 2008 |
[Fibrate-induced deterioration of renal function].
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Clofibric Acid; Female; Humans; Hypolipidemic A | 2009 |
Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chemok | 2005 |
Metabolomic study of cisplatin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Cisplatin; Clofibric Acid; Fanconi Syndrome; Fa | 2006 |
Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle.
Topics: Acute Kidney Injury; Animals; Carbon Radioisotopes; Clofibrate; Clofibric Acid; Creatinine; Glucuron | 1983 |
[Fat and renal failure--therapeutic aspects].
Topics: Acute Kidney Injury; Animals; Bezafibrate; Carnitine; Charcoal; Clofibrate; Clofibric Acid; Humans; | 1982 |
[Rhabdomyolysis with acute renal failure due to bezafibrate].
Topics: Acute Kidney Injury; Bezafibrate; Clofibrate; Clofibric Acid; Humans; Male; Middle Aged; Muscular Di | 1981 |
Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment.
Topics: Acute Kidney Injury; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clofibric Acid; Drug Interactio | 1997 |
Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group.
Topics: Acute Kidney Injury; Aged; Anticholesteremic Agents; Bezafibrate; Cardiopulmonary Bypass; Clofibric | 2000 |